Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Non-Current Debt (2021 - 2024)

Roivant Sciences (ROIV) has disclosed Non-Current Debt for 4 consecutive years, with $37.8 million as the latest value for Q2 2024.

  • For the quarter ending Q2 2024, Non-Current Debt fell 76.73% year-over-year to $37.8 million, compared with a TTM value of $37.8 million through Jun 2024, down 76.73%, and an annual FY2024 reading of $188.7 million, up 441.87% over the prior year.
  • Non-Current Debt was $37.8 million for Q2 2024 at Roivant Sciences, down from $188.7 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $204.0 million in Q4 2021 and bottomed at $32.6 million in Q1 2022.
  • Average Non-Current Debt over 4 years is $143.4 million, with a median of $164.4 million recorded in 2023.
  • The sharpest move saw Non-Current Debt crashed 80.84% in 2022, then soared 441.87% in 2024.
  • Year by year, Non-Current Debt stood at $204.0 million in 2021, then fell by 22.88% to $157.4 million in 2022, then rose by 9.3% to $172.0 million in 2023, then crashed by 78.02% to $37.8 million in 2024.
  • Business Quant data shows Non-Current Debt for ROIV at $37.8 million in Q2 2024, $188.7 million in Q1 2024, and $172.0 million in Q4 2023.